This report in the Roll Back Malaria Progress & Impact Series details previous malaria elimination and eradication efforts to date and summarizes ongoing progress in all malaria-endemic areas of the world.

Author: Rietveld A, Kurdova-Mintcheva R

Publication date: October 2011

Region: Global

Part of series: Roll Back Malaria Progress & Impact Series

Rapid reporting systems help countries identify and respond to infections in real time. This fact sheet provides an overview of rapid reporting and how it is being used in the field to record and convey information quickly, aiding malaria-elimination efforts.

Publication date: October 2011

Region: Africa

Part of the Roll Back Malaria Progress & Impact Series, this report demonstrates the dramatic successes achieved by the malaria community over the past ten years. As a result of greater commitment and increased resources being made available to national malaria control programs, interventions have reached vulnerable populations and thousands of lives have been saved. The report details the evolution and effectiveness of the Roll Back Malaria Partnership over the years, demonstrating how a strong, well-organized community can help deliver broad health benefits while relieving overburdened health systems.

Author: White Johansson EW, Newby H, Carvajal L, et al

Publication date: September 2011

Region: Global

Part of series: Roll Back Malaria Progress & Impact Series

Late-stage trials of an advanced malaria vaccine candidate—which, if approved, would become the world’s first malaria vaccine—are under way. This article, published in Health Affairs, recounts the pivotal roles played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine.

Author: Loucq C, Birkett A, Poland D, Botting C, Nunes J, Ethelston S

Publication date: June 2011

Region: Africa

This report details malaria research and development funding from 2004 to 2009, including how much funding went to each product area, who provided the funding, and how investments flowed from funders to recipients. The report assesses progress against the Global Malaria Action Plan funding goals to identify what is needed in the next decade and was followed in 2013 by From Pipeline to Product: Malaria R&D Funding Needs Into the Next Decade.

Publication date: June 2011

Region: Global

This report in the Roll Back Malaria Progress & Impact Series examines how private-sector investment in malaria control has improved cost-effectiveness at companies operating in malaria-endemic regions in Africa.

Author: Mouzin E, Sedlmayr R, Miller J, et al

Publication date: May 2011

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

Malaria is a leading cause of morbidity and mortality in children younger than five years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study, published in Malaria Journal, explores sociocultural and health communications issues among individuals who are responsible for or influence decisions on childhood vaccination at the community level.

Author: Ojakaa DI, Ofware P, Machira YW, et al

Publication date: May 2011

Region: Africa

This report, part of the Roll Back Malaria Progress & Impact Series, shows how Zambia has built up a strong disease-control program, with well-defined goals and organizational plans.

Author: Mouzin E, Mukonka V, Kamuliwo M, et al

Publication date: April 2011

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

This fact sheet provides an overview of the impact that global and national investment have had in the fight against malaria, with an emphasis on the importance of US support for the President’s Malaria Initiative and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Publication date: February 2011

Region: Africa

This report provides an overview of Nicaragua's health system and diagnostic needs. It is supported by individual case studies on Chagas disease, dengue, and malaria in Nicaragua. These studies focus on several factors influencing the health care system in Nicaragua, including recent trends, regional and national control strategies, financing and partnerships, and the unmet clinical needs associated with each illness.

Author: Sequeira M, Espinoza H, Amador JJ, Domingo G, Quintanilla M, de los Santos T

Publication date: February 2011

Region: Latin America

This fact sheet describes PATH's work to improve malaria diagnosis, treatment, and referral practices in the private sector to contain drug-resistant parasites in Cambodia.

Publication date: January 2011

Region: Asia

The first country report in the Roll Back Malaria Progress & Impact Series, published in collaboration with Senegal’s National Malaria Control Programme, describes how Senegal achieved a spectacular drop in its malaria burden in just five years.

Author: Mouzin E, Thior PM, Diouf MB, Sambou B

Publication date: November 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

​This report, part of the Roll Back Malaria Progress & Impact Series, provides an overview of mathematical modelling, explains its history in relation to epidemiology and malaria, and details its implications and uses for global and national malaria control and elimination planning. The report aims to expand the dialogue within the global malaria community—and among public health decision-makers in particular—on when and how mathematical modelling can help inform malaria control programs and policies.

Author: Chitnis N, Schapira A, Smith DL, Smith T, Hay SI, Steketee R

Publication date: November 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

The third report of the Roll Back Malaria Progress & Impact Series analyzes the impact of malaria control scale-up on child mortality over the last decade in 34 malaria-endemic African countries. Using the Lives Saved Tool, this report demonstrates the dramatic progress made toward achieving the Millennium Development Goals related to malaria and child survival—and the potential consequences of decreasing our commitment to fighting the disease.

Author: Eisele T, Larsen D, Walker N, Steketee R, Cibulskis R

Publication date: September 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

The second report in the Roll Back Malaria Progress & Impact Series benchmarks the remarkable progress and momentum that are building toward halting malaria in Africa.

Author: Johansson EW, Steketee R

Publication date: April 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

This report, the first in the Roll Back Malaria Progress & Impact Series, confirms that investment in malaria control is rapidly saving lives and reaping far-reaching benefits for countries. The report demonstrates that without sustained and predictable long-term funding, the significant contribution of malaria control toward achievement of the five Millennium Development Goals that are closely tied to malaria control, as well as progress toward achieving the 2010 Abuja target of universal intervention coverage, could be reversed.

Author: Johansson EW, Cibulskis R, Steketee R

Publication date: March 2010

Region: Africa

Part of series: Roll Back Malaria Progress & Impact Series

Clinical trials are a critical source of data for decisions around vaccine development. This fact sheet provides information about the phases of clinical trials.

Publication date: October 2009

Region: Global

This document is intended to start discussions around quantifying the need for safe injection equipment and the amount of infectious sharps waste produced by testing and treatment programs for diseases such as HIV/AIDS, tuberculosis, and malaria. The analysis was developed to support advocacy efforts to integrate injection safety as an essential element of all health care programs.

Publication date: June 2009

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, easy-to-read, low-cost test for malaria.

Publication date: May 2009

Region: Global

Part of series: Technology Updates

This poster presents a study to collect and characterize specimens from febrile patients who were suspected to have malaria, pedigree specimens against a panel of nucleic acid and serological markers, and draw early insights into data that would be generated by a multiplex diagnostic platform. Presented at The American Society of Tropical Medicine and Hygiene, December 7, 2008; New Orleans, LA.

Author: Gerlach JL, Waitumbi J, Koros J, et al

Publication date: December 2008

Region: Global